|Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.|
IF Tannock, D Osoba, MR Stockler, DS Ernst, AJ Neville, MJ Moore, ...
Journal of clinical oncology 14 (6), 1756-1764, 1996
|Bisphosphonates for breast cancer|
N Pavlakis, RL Schmidt, MR Stockler
Cochrane Database of Systematic Reviews, 2005
|Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III …|
NC Tebbutt, K Wilson, VJ Gebski, MM Cummins, D Zannino, ...
Journal of clinical oncology 28 (19), 3191-3198, 2010
|Single agent versus combination chemotherapy for metastatic breast cancer|
S Carrick, S Parker, CE Thornton, D Ghersi, J Simes, N Wilcken
Cochrane Database of Systematic Reviews, 2009
|Enzalutamide with standard first-line therapy in metastatic prostate cancer|
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
|Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials|
YY Soon, MR Stockler, LM Askie, MJ Boyer
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2009
|Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer|
M Stockler, NRC Wilcken, D Ghersi, RJ Simes
Cancer treatment reviews 26 (3), 151-168, 2000
|Bisphosphonates and other bone agents for breast cancer|
MHF Wong, MR Stockler, N Pavlakis
Cochrane database of systematic reviews, 2012
|Third consensus on medical treatment of metastatic breast cancer|
S Beslija, J Bonneterre, HJ Burstein, V Cocquyt, M Gnant, V Heinemann, ...
Annals of oncology 20 (11), 1771-1785, 2009
|Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials|
A Gennari, M Stockler, M Puntoni, M Sormani, O Nanni, D Amadori, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2011
|Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer|
P Glare, G Pereira, LJ Kristjanson, M Stockler, M Tattersall
Supportive Care in Cancer 12 (6), 432-440, 2004
|Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer|
MR Stockler, F Hilpert, M Friedlander, MT King, L Wenzel, CK Lee, F Joly, ...
Journal of Clinical Oncology 32 (13), 1309, 2014
|Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers|
KB Kuchenbaecker, L McGuffog, D Barrowdale, A Lee, P Soucy, J Dennis, ...
JNCI: Journal of the National Cancer Institute 109 (7), 2017
|Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial|
MR Stockler, R O'Connell, AK Nowak, D Goldstein, J Turner, ...
The lancet oncology 8 (7), 603-612, 2007
|Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer|
MR Stockler, VJ Harvey, PA Francis, MJ Byrne, SP Ackland, B Fitzharris, ...
J Clin Oncol 29 (34), 4498-4504, 2011
|Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 …|
D Stark, M Nankivell, E Pujade-Lauraine, G Kristensen, L Elit, M Stockler, ...
The lancet oncology 14 (3), 236-243, 2013
|Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 …|
GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ...
The Lancet Oncology 17 (6), 727-737, 2016
|Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review|
CA Hauser, MR Stockler, MHN Tattersall
Supportive Care in Cancer 14 (10), 999-1011, 2006
|Evidence-based medicine: useful tools for decision making.|
JC Craig, LM Irwig, MR Stockler
The Medical Journal of Australia 174 (5), 248-253, 2001
|Second consensus on medical treatment of metastatic breast cancer|
S Beslija, J Bonneterre, H Burstein, V Cocquyt, M Gnant, P Goodwin, ...
Annals of oncology 18 (2), 215-225, 2007